FIELD: medicine.
SUBSTANCE: drainage contains the following ratio of components, in 1 ml of mixture: chitosan succinate 0.02-0.03 g; hyauronic acid dialehyde 0.002-0.003g; lucentis 0.1-0.2 ml; phosphate buffer - the remaining part.
EFFECT: application of the invention reduces inflammatory reaction and development of excessive processes of proliferation of surgery zone, improves intraocular fluid filtration and ensures normalisation of intraocular pressure.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DRAINAGE FOR TREATMENT OF GLAUCOMA | 2015 |
|
RU2610407C1 |
| DRAIN TUBE FOR TREATING GLAUCOMA | 2014 |
|
RU2578424C1 |
| DRAINAGE FOR GLAUCOMA SURGERY | 2016 |
|
RU2613413C1 |
| METHOD OF SURGICAL TREATMENT OF REFRACTORY GLAUCOMA AT TERMINAL STAGE | 2012 |
|
RU2500367C1 |
| DRAINING MEANS FOR SURGICALLY TREATING GLAUCOMA CASES | 2005 |
|
RU2304946C2 |
| METHOD OF SURGICAL TREATMENT OF OPEN GLAUCOMA | 2012 |
|
RU2491043C1 |
| METHOD OF TREATING GLAUCOMA AT TERMINAL STAGE OF DISEASE | 2007 |
|
RU2359646C2 |
| METHOD FOR TREATING PRIMARY OPEN-ANGLE GLAUCOMA | 2019 |
|
RU2735378C1 |
| METHOD FOR ACTIVATING THE UVEOSCLERAL PATHWAY OF OUTFLOW OF INTRAOCULAR LIQUID | 2018 |
|
RU2712640C1 |
| SURGICAL METHOD FOR TREATING PATIENTS FOR GLAUCOMA | 2000 |
|
RU2195903C2 |
